MTIP | The European healthcare software investor.

At MTIP, our purpose is clear:
Unlocking value, improving lives. We focus on scaling healthcare software innovations that have the potential to drive significant impact, creating value and transforming the healthcare landscape.

MTIP co-workes drinking coffee at a table

Portfolio

Our Success Stories

MTIP's involvement has gone far beyond financial backing - they are strategic, action-oriented and deeply engaged in helping us build long-term value.

Geir Arnhoff

Founder & CEO, Dossier

Compared to other investors we've worked with, MTIP stands out as knowledgeable, analytical, and consistently hard-working. They definitely add value, which is something rare to find among investors.

Dr. Farzana Rahman

CEO, Hexarad

The MTIP team are sector specialists, are deeply embedded in the industry, and are able to provide valuable insights and advice. They have a strong view of the market and the ability to build and support a contrarian perspective. This is a clear differentiation.

Dr. Kai Eberhardt

Co-Founder & CEO Oviva

MTIP’s focus on healthcare, means that their impact is more than just to scale and execution. They really are a business partner, and they engage heavily with their portfolio companies, which helps us make better decisions.

Matt Walz

CEO of Trialbee

Our partnership with MTIP is a qualitative leap forward. This strategic partnership will boost our growth and create success for both parties.

Cristian Pascual

Co-Founder & CEO of Mediktor

Media

Trends and insights
from our health experts.

All

Blog

News

Press

News

MTIP Announces Majority Investment in Verifarma

MTIP is pleased to announce a majority investment in Verifarma, a leading provider of integrated serialization, traceability, and regulatory compliance solutions for the pharmaceutical industry, headquartered in Spain.

Read more

News

Successful Oviva Series D Round Securing €200m to Expand AI-Enabled Healthcare

MTIP is pleased to announce the successful completion of Oviva’s €200m Series D financing round comprising a mix of primary and secondary capital.

Read more

News

MTIP Achieves Successful Exit of Trialbee

MTIP is pleased to announce the successful exit of its majority position in Trialbee.

Read more

News

MTIP Announces Successful Acquisition of Cynerio by Axonius

MTIP is proud to announce the successful acquisition of its portfolio company Cynerio by Axonius, one of the world’s fastest-growing cybersecurity companies.

Read more

News

MTIP Acquires Majority Stake in Dossier Solutions

MTIP is pleased to announce the acquisition of a majority stake in Dossier Solutions, a leading healthcare competency management SaaS provider.

Read more

Blog

Success Factors of Growth-Stage Digital Health Companies: Systematic Literature Review

Our Investment Research Analyst, Estelle Pfitzer, and her co-authors have published a valuable systematic review in the Journal of Medical Internet Research. Alongside Tobias Kowatsch, Laura Bitomsky, Marcia Nißen, and Christoph Kausch, Estelle highlights critical success factors for growth-stage digital health companies in an increasingly competitive and regulated landscape.

Read more

News

MTIP Named Sector Specialist of the Year at Real Deals ESG Awards

MTIP wins Sector Specialist of the Year at Real Deals ESG Awards 2024!

Read more

News

MTIP Welcomes Two New Board Members

MTIP appoints Daniela Nienstedt and Benjamin Gilgen to Board of Directors

Read more

News

MTIP Leads Growth Financing Round for Hexarad

MTIP is pleased to announce MTIP Fund II’s ninth platform investment in Hexarad, leading the €13 million growth round with reinvestment from existing shareholders.

Read more

News

MTIP is now a Certified B Corporation™!

We are proud to announce that MTIP has been certified as a B Corporation with a score of 107.5.

Read more

News

MTIP Invests $15 Million in Caresyntax

MTIP invested $15 million to accelerate Caresyntax's commercial growth and to expand its data-driven surgery platform.

Read more

News

MTIP Office Featured in Swiss Office Blog

The MTIP office in Basel is featured in the Swiss office blog called “Büroblog Schweiz“ which provides information about interesting aspects of the office world.

Read more

News

Christoph Kausch selected by Real Deals as most influential for 2022

We are happy to share the news that Dr. Christoph Kausch, our Managing Partner at MTIP, made the list for Real Deals most influential for 2022.

Read more

News

MTIP Closes Second Healthtech Growth Fund Above Target With $250M of Commitments

‘Dark green’ fund aims to help healthtech innovators to become global leaders

Read more

News

MTIP invests in Mediktor

Investment led by MTIP enables the Spanish healthtech company Mediktor to keep on improving their elaborate technology and expand their international presence.

Read more

News

MTIP participates in Oviva’s new $80m Series C funding

Ovivia raises $80 million financing round

Read more

News

MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

Investment led by MTIP enables the company to reduce the risk of clinical research, improve R&D productivity, and accelerate scientific breakthroughs through artificial intelligence (AI) and natural language processing (NLP).

Read more

Blog

Trialbee – our hero in patient matching and recruiting for clinical trials

How can you keep the engagement rate of patients in clinical trials at a high level? Our portfolio company Trialbee has developed a solution for this problem with their patient recruitment and engagement platform. Learn more about the company in our latest blog post.

Read more